to go to the previous page
Transforming Regulatory Information Into Actionable Regulatory Intelligence for Emerging Markets
Monday, June 25, 2012
10:00 AM to 11:30 AM
Kim Quaintance, Eisai Inc., United States
Linda is Sr. Director of Regulatory Policy & Intelligence at Sanofi and has held RA positions at Bayer and Block Drug/GSK, with global regulatory responsibilities for submissions, life cycle management and due diligence. She is a RAPS Fellow, RAC for US/CDN/EU, and is on the RAPS Board.
Agustina Bisio, Administración Nacional De Medicamentos, Alimentos Y Tecnología Médica (ANMAT), Argentina
Laura Castanheira, National Health Surveillance Agency (ANVISA), Brazil
Brooke has more than 10 years Regulatory experience as a strategist and publishing expert in global markets. She is the Chairperson of the DIA Regulatory Intelligence SIAC and active member in various organizations to promote Regulatory awareness.
Industry representatives and an emerging market health authority will discuss gathering and management of regulatory intelligence from rapidly evolving emerging markets.
Identify various sources for regulatory information
Describe real-life experiences working with emerging markets
Discuss methods for implementing and disseminating regulatory intelligence within our organization.
Audio Synchronized to PowerPoint